Canopy Growth (CGC) Non Operating Income (2019 - 2025)
Canopy Growth's (CGC) quarterly Non Operating Income came in at -$25.7 million in Q4 2025, up 63.2% year-on-year from -$15.8 million in Q4 2024, and down 329.08% quarter-over-quarter from $11.2 million in Q3 2025.
Canopy Growth (CGC) Non Operating Income (2019 - 2025) Analysis & Trends
Canopy Growth has disclosed Non Operating Income across 7 years of filings, most recently posting -$25.7 million for Q4 2025.
- Non Operating Income for Q4 2025 came in at -$25.7 million, up 63.2% year-over-year; the trailing twelve-month figure through Dec 2025 was -$169.3 million (up 12.38% YoY), and the FY2025 annual result was -$334.4 million, down 85.72% from the prior year.
- Non Operating Income came in at -$25.7 million for Q4 2025 at Canopy Growth, down from $11.2 million in the prior quarter.
- In the past five years, Non Operating Income ranged from a high of $472.4 million in Q2 2021 to a low of -$646.8 million in Q1 2022.
- The 5-year median for Non Operating Income is -$46.2 million (2022), against an average of -$42.1 million.
- Across the five-year window, Non Operating Income surged 1258.78% in 2021 and tumbled 1892.69% in 2025, its largest moves.
- Canopy Growth's Non Operating Income stood at $27.2 million in 2021, then plunged by 412.83% to -$85.1 million in 2022, then slumped by 47.66% to -$125.6 million in 2023, then surged by 44.3% to -$70.0 million in 2024, then soared by 63.2% to -$25.7 million in 2025.
- The last three Non Operating Income figures came in at -$25.7 million (Q4 2025), $11.2 million (Q3 2025), and -$13.4 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | -216.00 Mn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 20.00 Mn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | -7.50 Mn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | -504,111.66 |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 53.40 Mn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | -13.65 Mn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 5.71 Mn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | -23.23 Mn |
| 10 | Canopy Growth | 11.38 Mn | -137.31 Mn | 15.39 Mn | -25.75 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -25.75 Mn |
| Sep 30, 2025 | 11.24 Mn |
| Jun 30, 2025 | -13.43 Mn |
| Mar 31, 2025 | -141.41 Mn |
| Dec 31, 2024 | -69.98 Mn |
| Sep 30, 2024 | -62.53 Mn |
| Jun 30, 2024 | -68.65 Mn |
| Mar 31, 2024 | 7.89 Mn |
| Dec 31, 2023 | -125.63 Mn |
| Sep 30, 2023 | -95.73 Mn |
| Jun 30, 2023 | 34.32 Mn |
| Mar 31, 2023 | 296.37 Mn |
| Dec 31, 2022 | -85.08 Mn |
| Sep 30, 2022 | -29.96 Mn |
| Jun 30, 2022 | -192.62 Mn |
| Mar 31, 2022 | -646.76 Mn |
| Dec 31, 2021 | 27.20 Mn |
| Sep 30, 2021 | 155.56 Mn |
| Jun 30, 2021 | 472.39 Mn |
| Mar 31, 2021 | -289.78 Mn |